- Home
- PTGX vs SKT Comparison
PTGX vs SKT Comparison
Compare PTGX & SKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PTGX | SKT |
|---|---|---|
| Founded | 2006 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 3.9B |
| IPO Year | 2016 | 1993 |
Fundamental Metrics
Financial Performance| Metric | PTGX | SKT |
|---|---|---|
| Price | $89.53 | $32.09 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 8 |
| Target Price | ★ $86.44 | $36.13 |
| AVG Volume (30 Days) | ★ 898.7K | 641.8K |
| Earning Date | 11-06-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 3.65% |
| EPS Growth | N/A | ★ 8.00 |
| EPS | 0.72 | ★ 0.94 |
| Revenue | $209,217,000.00 | ★ $575,140,000.00 |
| Revenue This Year | N/A | $2.91 |
| Revenue Next Year | $296.47 | $4.62 |
| P/E Ratio | $124.48 | ★ $34.15 |
| Revenue Growth | N/A | ★ 10.01 |
| 52 Week Low | $33.70 | $28.69 |
| 52 Week High | $93.25 | $36.76 |
Technical Indicators
Market Signals| Indicator | PTGX | SKT |
|---|---|---|
| Relative Strength Index (RSI) | 64.67 | 37.12 |
| Support Level | $83.52 | $32.43 |
| Resistance Level | $90.85 | $33.79 |
| Average True Range (ATR) | 2.63 | 0.66 |
| MACD | -0.33 | -0.16 |
| Stochastic Oscillator | 83.62 | 10.82 |
Price Performance
Historical ComparisonAbout PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About SKT Tanger Inc.
Tanger Inc is an owners and operators of outlet and open-air centers in the United States and Canada. It is a fully-integrated, self-administered and self-managed REIT, which focuses on developing, acquiring, owning, operating and managing outlet and open-air shopping centers. Its consolidated portfolio consisted of 31 outlet centers and 2 open-air lifestyle centers, with a total gross leasable area of approximately 13.0 million square feet.